Disease-specific iPS cell models in neuroscience
M Peitz1, J Jungverdorben, O Brüstle
1Institute of Reconstructive Neurobiology, University of Bonn LIFE & BRAIN Center, and LIFE & BRAIN GmbH, Sigmund-Freud Strasse 25, D- 53127 Bonn, Germany. brustle@uni-bonn.de
Current Molecular Medicine
|May 7, 2013
Summary
Human induced pluripotent stem (hiPS) cells offer a powerful in vitro model for studying neurodegenerative diseases. These patient-specific cells overcome limitations of traditional models, aiding research into disease mechanisms.
Area of Science:
- Neuroscience
- Stem Cell Biology
- Genetics
Background:
- Neurodegenerative diseases involve progressive neural cell loss, posing research challenges due to limited human tissue access.
- Existing models like cell lines and animal models often lack physiological relevance and human context.
- Disease initiation precedes symptoms, making late-stage tissue analysis insufficient for understanding early molecular events.
Purpose of the Study:
- To review the progress and applications of human induced pluripotent stem (hiPS) cell-based models in neurodegenerative disease research.
- To highlight the advantages of hiPS cells over traditional experimental systems.
- To discuss advancements in assessing the quality of hiPS cell lines for reliable disease modeling.
Main Methods:
- Utilizing patient-derived somatic cells to generate human induced pluripotent stem (hiPS) cells.
- Employing hiPS cells for in vitro modeling of neurological disorders.
- Reviewing current literature on hiPS cell applications and quality assessment techniques.
Main Results:
- hiPS cells provide patient-specific, virtually unlimited cellular resources for in vitro disease modeling.
- These models offer a more physiologically relevant context compared to cell lines or animal models.
- Advances in quality assessment are crucial for ensuring the reliability of hiPS cell-based studies.
Conclusions:
- hiPS cell technology represents a significant advancement in modeling neurodegenerative diseases.
- This approach facilitates the study of molecular pathomechanisms in a humanized context.
- Further development in hiPS cell quality control will enhance their utility in translational research.
Related Concept Videos
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.